News Detail

Bengaluru, 16 March 2025: Indian pharmaceutical companies are aggressively expanding their US presence through a wave of acquisitions, likely as a hedge against future uncertainties. Leading players like Sun Pharma, Syngene, Senores, and Zydus have all made strategic purchases, r......
View Details
Source : The Hindu Businessline
India
pharma companies
regulations
Related News
- Rise in pediatric pneumonia cases underscores the increasing issue of antibiotic resistance (16-03-2025)
- Extended use of steroids linked to risk of glaucoma, AIIMS docs caution (16-03-2025)
- WHO announces one batch of falsified Oxycontin 80mg identified in the WHO European Region (15-03-2025)
- Counterfeit medicine manufacturing units exist in states like UP, HP and Uttarakhand: Dinesh Gundu Rao in Assembly (15-03-2025)
- Delhi Police busted a drug supply gang, large quantity of Alprazolam-Tramadol seized, two arrested (15-03-2025)
- UP DCA to intensify inspections to combat infiltration of counterfeit drugs to UP from other states (15-03-2025)
- UN Commission approves WHO recommendations to place psychoactive substances under international control (15-03-2025)
- Cosmetics stakeholders call for separate regulations and better central-state harmonisation (15-03-2025)
- Punjab: 15 patients experience mild reactions after IV fluid use in Sangrur hospital (14-03-2025)
- Trial of Offences must be conducted by a Court of Sessions, there is no bar on a Magistrate taking cognizance of such offences: Jammu and Kashmir and Ladakh HC (14-03-2025)